The Solid Biosciences team was honored to join the Duchenne muscular dystrophy community in recognizing World Duchenne Awareness Day.
Only together can we end this devastating disease.
- IGNITE DMD Phase I/II Clinical Trial Patient Screening Has Resumed -
Ilan Ganot, Co-Founder and CEO, Assumes Additional Role of PresidentGilad Hayeem, Co-Founder, President and Board Member, Retires to Pursue Other Activities
We’re pleased to share with you that the FDA has lifted the clinical hold on IGNITE DMD.
- Activities to Resume Enrollment in IGNITE DMD Phase I/II Clinical Trial are Underway
- Conference Call Scheduled for Today at 8:30 A.M. ET
Please subscribe to receive our latest news